To investigate the role of Ran in CRC, we established gain- and loss-of-function cell models by transfecting CRC cells with a plasmid expressing Ran or siRNA oligos targeting Ran (siRan), respectively. This evidence concerns the gene RAN and colorectal carcinoma.